share_log

中国生物制药(01177):受托人根据限制性股份奖励计划进一步购买675万股

China Biopharmaceutical (01177): Trustee further purchases 6.75 million shares under the Restricted Share Award Program

Zhitong Finance ·  Apr 8 05:54

China Biopharmaceutical (01177) issued an announcement. On April 8, 2024, the trustee purchased 6 more from the market...

According to the Zhitong Finance App, China Biopharmaceutical (01177) issued an announcement. On April 8, 2024, the trustee purchased a further 6.75 million shares from the market and held them in trust on behalf of the selected participants in accordance with the terms and conditions of the plan rules. The average cost per share is approximately HK$2.83.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment